Concepedia

Lilan Xin

LX

Statistics

Publications

8

Citations

135

H-Index

8

Active since

2023

Affiliations

Wuhan University(Current)

Zhongnan Hospital of Wuhan University

State Key Laboratory of Virology

Lilan Xin is an author at Wuhan University specializing in medicine, radiation oncology, and breast cancer.

ORCID

Top concepts

Publications per year

2023–2024

8

Publications

8

Discovery of Novel ERα and Aromatase Dual-Targeting PROTAC Degraders to Overcome Endocrine-Resistant Breast Cancer

Lilan Xin, Chao Wang, Yan Cheng et al. · Journal of Medicinal Chemistry · 2024 · 28 citations · Full text

Identification of Novel Dual-Target Estrogen Receptor α Degraders with Tubulin Inhibitory Activity for the Treatment of Endocrine-Resistant Breast Cancer

Xiangping Deng, Xiaofei Deng, Wentao Ning et al. · Journal of Medicinal Chemistry · 2023 · 20 citations · Full text

FLT3-selective PROTAC: Enhanced safety and increased synergy with Venetoclax in FLT3-ITD mutated acute myeloid leukemia

Yuxin Tan, Lilan Xin, Qian Wang et al. · Cancer Letters · 2024 · 20 citations

, , +9

Discovery of estrogen receptor α targeting caged hypoxia-responsive PROTACs with an inherent bicyclic skeleton for breast cancer treatment

Baohua Xie, Bin Xu, Lilan Xin et al. · Bioorganic Chemistry · 2023 · 17 citations

, , +8

Novel Acyl Thiourea-Based Hydrophobic Tagging Degraders Exert Potent Anti-Influenza Activity through Two Distinct Endonuclease Polymerase Acidic-Targeted Degradation Pathways

Xiaoyu Ma, Xueyun Wang, Feifei Chen et al. · Journal of Medicinal Chemistry · 2024 · 15 citations

1–5 of 8